show that BCMA-targeting chimeric antigen receptor (CAR)-T cells generated from T cells exposed to G-CSF in vivo have a favorable phenotype and effective anti-tumor activity, thus demonstrating that apheresis products collected for autologous stem cell transplantation are a suitable source of T cells for CAR-T cell production. This evidence concerns the gene CSF3 and neoplasm.